STRATA Skin Sciences (SSKN) Cash from Operations Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.89% |
| Sep 30, 2025 | -16.18% |
| Jun 30, 2025 | -39.16% |
| Mar 31, 2025 | -23.90% |
| Dec 31, 2024 | -8.78% |
| Sep 30, 2024 | -19.39% |
| Jun 30, 2024 | 53.21% |
| Mar 31, 2024 | -34.45% |
| Dec 31, 2023 | 4.48% |
| Sep 30, 2023 | -25.27% |
| Jun 30, 2023 | 56.53% |
| Mar 31, 2023 | -73.27% |
| Dec 31, 2022 | -37.61% |
| Sep 30, 2022 | -26.69% |
| Jun 30, 2022 | -15.59% |
| Mar 31, 2022 | -19.45% |
| Dec 31, 2021 | -13.80% |
| Sep 30, 2021 | -1.60% |
| Jun 30, 2021 | 27.08% |
| Mar 31, 2021 | 16.10% |
| Dec 31, 2020 | -1.60% |
| Sep 30, 2020 | 19.09% |
| Jun 30, 2020 | 17.56% |
| Mar 31, 2020 | 17.00% |
| Dec 31, 2019 | 18.80% |
| Sep 30, 2019 | 17.03% |
| Jun 30, 2019 | 15.07% |
| Mar 31, 2019 | 15.41% |
| Dec 31, 2018 | 17.94% |
| Sep 30, 2018 | 18.86% |
| Jun 30, 2018 | 50.74% |
| Mar 31, 2018 | 14.98% |
| Dec 31, 2017 | 18.90% |
| Sep 30, 2017 | 16.12% |
| Jun 30, 2017 | 17.34% |
| Mar 31, 2017 | 16.59% |
| Dec 31, 2016 | 18.65% |
| Sep 30, 2016 | 16.27% |
| Jun 30, 2016 | 48.83% |
| Mar 31, 2016 | 20.77% |
| Dec 31, 2015 | 15.68% |
| Sep 30, 2015 | 21.04% |